Similarly, depression can occur from 20% up to stroke, with poststroke depression occurring in up to 30% of the patients [7] . The development of psychiatric symptoms is associated with a poor functional prognosis and a negative impact on the patient's quality of life. Conversely, in population-based prospective studies, individuals with depression or depressive symptoms have increased cardiovascular morbidity and mortality [8] . However, the large majority of these epidemiological studies rely on depression scales or self-rating questionnaires for depression rather than diagnostic interviews and did not mental disorders such as anxiety and substance use disorders.
As these studies could not or only partially adjust for the presence of CVRF other than depression, the question of whether or not depression is an independent risk factor for CVD is still not resolved. In addition, not only depression but in patients with CAD [9] . Potential mechanisms involved in this association of CVD and mental disorders have only been partially elucidated. Several non-mutually exclusive hypotheses have been suggested to explain this association: a) mental disorders could increase vulnerability to CVD; b) CVD or their treatment could favour the development of mental disorders and c) CVD/CVRF could share common pathogenic processes.
Potential mechanisms underlying increased vulnerability to CVD in individuals with mental disorders
Several mechanisms have been postulated, starting with the fact that subjects with mental disorders may display damaging health behaviours. For example, depression and anxiety disorders are associated with poor health behaviour such as smoking or unbalanced diet. In addition, depressed patients are less compliant with medical therapy [10] , which could contribute to an increased risk of CVD in individuals treated for high blood pressure, dyslipidaemia or diabetes.
Furthermore, hormonal factors have also been suggested to play a role. In particular, the hypothalamic-pituitary-adrenocortical axis (HPA) and the sympatho-medullary system are two primary components of the stress response and could mediate the association between depressive or anxiety disorder and the subsequent development of CVD. Administration of corticosteroids induces hypercholesterolemia, hypertriglyceridemia and hypertension leading to endothelial dysfunction. Therefore, HPA hyperactivity, which has been frequently observed in patients with depression or anxiety disorders, could contribute to increased vulnerability to CVD in these individuals. Similarly, depression and anxiety disorders are associated with dysregulation of the sympathoadrenal system, hence elevated norepinephheart, blood vessels and platelets. Likewise, decreased parasympathetic tone in depression is associated with decreased heart rate variability, a possible risk factor for arrhythmia and cardiovascular mortality [11] .
Finally, antidepressants drug used for the treatment for mood and anxiety disorders are also suspected to be involved in the occurcardiovascular system by in particular by potentially increasing arrhythmias [12] .
Potential mechanisms underlying increased vulnerability to mental disorders in individuals with CVRF /CVD
CVRF such as hypertension, cigarette smoking, hypercholesterolemia and diabetes are risk factors for the incidence of late-onset depression or "vascular depression", related probably to subcortical brain lesions [13] . Depression could also be a consequence of spe--ticular propranolol has been shown to be associated with higher frequency of anti-depressant prescription [14] , but this has not been artery disease and in particular myocardial infarction (MI) and deof chronic illness on mood.
However, as the prevalence of depression does not correlate with the degree of cardiac dysfunction, this hypothesis can be questioned [6] . Finally, it has been suggested that CAD may contribute to
Shared common pathophysiological processes
Several common pathophysiological processes have also been suggested to explain the association between depression and -tion activity, metabolic abnormalities linked to reduced intake of essential fatty acids, sleep disturbances, migraine and common genetic variants. These mechanisms could either act as common pathophysiological process underlying the development of CVD and mental disorders or an intermediate process within the potentially bi-directional causal relationship between CVD and mental disorders.
--ticipates centrally in all stages of the atherosclerotic process from the very early adhesion of monocytes to endothelial cells to atherosclerotic plaque growth progression and rupture. Furthermore, in large-scale epidemiological studies, CRP, tumour necrosis factor-α cardiovascular events. However, it is not clear whether some of the mediators of the atherosclerotic disease.
Accumulated evidence also suggests that there is a chronic low- [15] . Moreover, treatments including the cytokine interferon-α lead to depression in up to 50% of patients [15] . Moreover, CRP has been found to be higher in patients with bipolar-I disorder during acute mania and the depressive phase than in healthy controls [16] . Currently, available disorders are largely cross-sectional and therefore the direction of the development of CAD and depression, it is possible that genetic depression.
Disturbed sleep is another risk factor that could predispose to both mental disorders (in particular mood and anxiety disorders) and CVD or mediate the association between the two types of pathology. Circadian rhythm disturbances were found in both unipolar and bipolar mood disorders, although the direction of causality remains unclear [17] (REM) sleep period and decreased sleep intensity are potential biological markers of mood disorders, whereas sleep deprivation has shown to be one of the major risk factors for CVD and metabolic disease, with a four-fold increased risk of fatal cardiovascular events in severe OSA patients [18] . Recent studies also documented an association between poor sleep and increased plasma-levels of IL-6 and that may explain the association between disturbed sleep and CVD.
Persistent pain (more than three months) is another clinical characteristic that has shown to be associated with mental disorders and CVD. Indeed several studies documented associations between chronic pain and anxiety or depressive disorders.
A recent study has also demonstrated an association between back pain, coronary heart events and mortality in elderly women. It has been hypothesised that pain could be an intermediate factor contributing to reduced mobility, polypharmacy, obesity/malnutrition or sleep disturbances or a third factor underlying the association between CVRF/CVD and mental disorders. It is also possible that and heart disease. CAD mortality is positively associated with low plasma levels of omega-3 fatty acids [19] and omega-3 fatty acids -bined incidence of death, nonfatal MI and stroke.
Similarly, several studies suggest a negative association between high plasma levels of omega-3 fatty acids and the prevalence of major depression, post-partum depression and suicidal ideation [20] . CAD patients with depression also revealed lower plasma levels of omega-3 fatty acids than CAD patients without depression [21] . Regarding the role of genetic variants contributing to these pathologies, to our knowledge there is only twin study that considered depressive symptoms and CAD jointly [22] . It revealed a correlation across heritabilities of 0.42, suggesting that nearly 20% of variability in depressive symptoms and CAD was attributable to common genetic factors. Although there is no genome-wide association (GWAS) or linkage study which jointly included depression and CAD phenotypes, yet, research focusing either on depression or CAD has provided some preliminary evidence of overlapping signals for the two types of pathology suggesting the potential for common candidate genes.
Regarding potential candidates genes, polymorphisms involved in the above processes which could underlie both mental disorders and CVD/CVRF are of particular interest, e.g. polymorphisms refor example. Both mental disorders and CAD are "complex" traits, meaning that the causal pathways are likely to involve multiple -ment interaction.
Limitations of existing studies
Existing studies investigating potential associations between men--tions including in particular: 1) the use of clinical rather than epidemiological samples 2) the lack of a comparison group 3) the application of psychiatric scales rather than structured diagnostic interviews 4) the assessment of the incidence of CVRF/CVD by self reports rather than clinical and biological information, 5) the lack of simultaneous assessments of both CVD and risk 6) the use of cross-sectional designs which leads to the problematic distinction between cause and consequence. These limitations -tions between mental disorders and CVRF/CVD.
The CoLaus/PsyCoLaus study
In order to prospectively study the complex mechanisms underlying eth association between mental disorders and CVD or risk factors, we have built the CoLaus/PsyCoLaus cohort study in Lausanne, Switzerland. This cohort is the follow-up of a cross sectional population-based study including 6738 participants aged and assessed between 2003 and 2006 for prevalence and determinants of cardiovascular risk factors (CoLaus) and a psychiatric arm including 3719 subjects aged 35-66 years (PsyCoLaus). These studies have been described in detail previously [23 24] . In summary in the CoLaus study all subjects underwent a detailed cardiovascular assessment including the measurement of a large panel of biologi-DNA chip.
All subjects in the PsyCoLaus study underwent a comprehensive psychiatric assessment based on a semi-structured diagnostic interview (Diagnostic Interview for Genetic studies: DIGS [25] ). In the current follow-up, which started in 2009 all subjects are re-contacted for a new cardiovascular and psychiatric assessment. In addition to the repetition of measures done at baseline, we are collecting -ders, physical activity, diet and cognitive function in elderly subjects. The prospective design together with the combined physical and psychiatric investigation in a population-based sample overcomes most of the limitations of previous research and therefore provides a unique opportunity to study the dynamic interplay between CVD/CVRF and mental disorders.
